Stone Ridge Asset Management LLC Glaukos Corp Transaction History

Stone Ridge Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$25.53 - $70.14 $119,250 - $327,623	-4,671 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$54.18 - $65.64 $43,344 - $52,512	-800 Reduced 14.62%	4,671 $254,000
Q1 2019 May 14, 2019	SELL	$50.75 - $80.54 $137,532 - $218,263	-2,710 Reduced 33.13%	5,471 $429,000
Q4 2018 Feb 14, 2019	BUY	$52.18 - $67.93 $45,448 - $59,167	871 Added 11.92%	8,181 $460,000
Q2 2018 Aug 13, 2018	BUY	$27.62 - $44.51 $11,048 - $17,804	400 Added 5.79%	7,310 $297,000
Q1 2018 May 14, 2018	BUY	$26.05 - $34.5 $180,005 - $238,395	6,910 New	6,910 $213,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.